Irbesartan
Brand name: Irbesartan
Rank #343 of 500 drugs by total cost
$30.1M
Total Cost
869,928
Total Claims
$30.1M
Total Cost
25,630
Prescribers
$35
Cost per Claim
142,074
Beneficiaries
2,185,238
30-Day Fills
$1,174
Avg Cost/Provider
34
Avg Claims/Provider
About Irbesartan
Irbesartan (sold as Irbesartan) was prescribed 869,928 times by 25,630 Medicare Part D providers in 2023, costing the program $30.1M. At $35 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 340 | Dabrafenib Mesylate (Tafinlar) | $30.4M | 2,377 |
| 341 | Testosterone (Testosterone) | $30.4M | 131,549 |
| 342 | Hydroxyzine Hcl (Hydroxyzine Hcl) | $30.2M | 1,474,936 |
| 343 | Irbesartan (Irbesartan) | $30.1M | 869,928 |
| 344 | Amiodarone Hcl (Amiodarone Hcl) | $29.9M | 1,007,679 |
| 345 | Esketamine Hcl (Spravato) | $29.0M | 20,816 |
| 346 | Warfarin Sodium (Warfarin Sodium) | $28.9M | 2,126,832 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology